Tayebi, S.; Tremblay, S.; Koehler, J.; Lazarovich, A.; Blank, F.; Hsu, W.-W.; Verma, S.; Sidana, A.
Prebiopsy Magnetic Resonance Imaging Followed by Combination Biopsy for Prostate Cancer Diagnosis Is Associated with a Lower Risk of Biochemical Failure After Treatment Compared to Systematic Biopsy Alone. Diagnostics 2025, 15, 698.
https://doi.org/10.3390/diagnostics15060698
AMA Style
Tayebi S, Tremblay S, Koehler J, Lazarovich A, Blank F, Hsu W-W, Verma S, Sidana A.
Prebiopsy Magnetic Resonance Imaging Followed by Combination Biopsy for Prostate Cancer Diagnosis Is Associated with a Lower Risk of Biochemical Failure After Treatment Compared to Systematic Biopsy Alone. Diagnostics. 2025; 15(6):698.
https://doi.org/10.3390/diagnostics15060698
Chicago/Turabian Style
Tayebi, Shima, Samuel Tremblay, Jason Koehler, Alon Lazarovich, Fernando Blank, Wei-Wen Hsu, Sadhna Verma, and Abhinav Sidana.
2025. "Prebiopsy Magnetic Resonance Imaging Followed by Combination Biopsy for Prostate Cancer Diagnosis Is Associated with a Lower Risk of Biochemical Failure After Treatment Compared to Systematic Biopsy Alone" Diagnostics 15, no. 6: 698.
https://doi.org/10.3390/diagnostics15060698
APA Style
Tayebi, S., Tremblay, S., Koehler, J., Lazarovich, A., Blank, F., Hsu, W.-W., Verma, S., & Sidana, A.
(2025). Prebiopsy Magnetic Resonance Imaging Followed by Combination Biopsy for Prostate Cancer Diagnosis Is Associated with a Lower Risk of Biochemical Failure After Treatment Compared to Systematic Biopsy Alone. Diagnostics, 15(6), 698.
https://doi.org/10.3390/diagnostics15060698